A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis

Author

Bukiej, Aleksandra

Source

Case Reports in Rheumatology

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-3, 3 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-07-13

Country of Publication

Egypt

No. of Pages

3

Main Subjects

Diseases

Abstract EN

Sclerosing mesenteritis (SM) is a chronic nonspecific mesenteric inflammation.

I report a case of a 72-year-old male treated with etanercept for psoriatic arthritis for 7 years who developed abdominal discomfort, urinary retention, acute kidney injury, and bilateral ureteric obstruction.

CT abdomen revealed retroperitoneal mass.

Biopsy showed sclerosing mesenteritis.

One year later, after discontinuation of etanercept, CT abdomen showed regression of the mass.

To my knowledge, this is first case report of reversible sclerosing mesenteritis associated with etanercept therapy.

American Psychological Association (APA)

Bukiej, Aleksandra. 2020. A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis. Case Reports in Rheumatology،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1151255

Modern Language Association (MLA)

Bukiej, Aleksandra. A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis. Case Reports in Rheumatology No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1151255

American Medical Association (AMA)

Bukiej, Aleksandra. A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis. Case Reports in Rheumatology. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1151255

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1151255